Drugmaker In IP Fight With Mylan Calls EPO Ruling 'Irrelevant'
Neurim Pharmaceuticals' lawyer told a London judge at the start of its trial against Mylan on Thursday it is "irrelevant" that a European Patent Office division revoked its insomnia medication patent,...To view the full article, register now.
Already a subscriber? Click here to view full article